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Impact of surgery on nitric oxide in rats: Evidence for activation of
inducible nitric oxide synthase. We investigated the effect of euvolemic
surgical preparation, on chemical indices of activity of the nitric oxide
(NO) system, in anesthetized, acutely prepared rats. The urinary excretion
of NO2+NO3 (UNOXV) and cGMP (UCCMPV) increased progressively
during the experiment. Pretreatment with aminoguanidine or dexameth-
asone, inhibitors of inducible NO synthase (iNOS), prevented the increase
in UNOXV and UCOMPV but had no impact on mean arterial pressure(BP), renal vascular resistance (RVR) or GFR. Since these variables did
not change in the conscious rat, the increased UN(xV results from some
aspect of the acute surgical preparation. When acutely prepared rats
received L-NAME, a non-specific NOS inhibitor, BP and RVR increased
but paradoxical increases in UNOXV and U(;MpV were also seen. Non-
selective NOS inhibition (+L-NAME) was fatal in 50% of acutely
prepared rats, causing cardiac contracture. The same dose of L-NAME
produced no deaths in either conscious chronically catheterized rats or in
acutely prepared rats, previously subjected to sterile surgery and acute
L-NAME in the conscious state. These data indicate that acute, non-
sterile surgery induces expression of iNOS, hut that the additional NO
generated has no obvious cardiovascular/renal actions. Acute UN0XV and
UCGMPV do not predict total NO production, or "hemodynamically active"
NO. Generalized NO inhibition in rats acutely stressed by surgery/
anesthesia can be fatal.
Nitric oxide (NO) is produced enzymatically from L-arginine
and activates soluble guanylate cyclase to form cyclic guanosine
monophosphate (cGMP) [1]. Increased concentration of cGMP in
vascular smooth muscle cells leads to reduced tone. Abundant
evidence indicates a major physiologic role for NO-cGMP in
regulation of systemic vascular resistance, arterial blood pressure
(BP) and renal hemodynamics [1—5]. NO originating from consti-
tutive NO synthases (NOS) provides an important vasodilatory
stimulus that balances the vasoconstrictor effects of the sympa-
thetic nervous system (SNS) and the renin-angiotensin system
(RAS) [2, 4, 6J. In response to general anesthesia/acute surgical
preparation, plasma volume, cardiac output and renal blood flow
tend to fall, the SNS and RAS are activated and systemic, renal
and other regional vascular resistances may increase [7—101.
Endothelial eicosanoids are also stimulated and may attenuate
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vasoconstriction triggered by the SNS and the RAS in acutely
prepared animals [IIj.
The present studies were conducted to assess the influence on
the NO system of acute, extensive, nonsterile surgical preparation
for renal micropuncture. Experiments were conducted in anesthe-
tized, acutely prepared rats and were compared to conscious,
unstressed rats, catheterized at least one week earlier. Measure-
ments were made of BP, renal hemodynamics, urinary excretion
of the stable oxidation products of NO (nitrite and nitrate =NOx;
UNOXV), plasma cGMP concentration (PGMp) and urinary
cGMP excretion (UCGMPV). Since we found that acute anesthesia/
surgery increased UNOXV and UcMlV, additional studies inves-
tigated whether the increased UNOXV originated from increased
NO synthesis. Acute surgery was conducted on rats treated either
with the inducible NOS (iNOS) inhibitors aminoguanidine (AG)
or dexamethasone (DEX) [12, 13j, or N-nitro-L-arginine methyl
ester (L-NAME), a nonspecific NOS inhibitor [1, 2].
Methods
Studies were conducted on 38 female Sprague-Dawley rats aged
3 to 5 months and obtained from Harlan Sprague Dawley, Inc.
(Indianapolis). Rats were shipped to the West Virginia University
Medical School Animal Care Facility at least seven days prior to
study and were allowed ad libitum access to drinking water and a
diet containing approximately 24% protein and 0.5% sodium.
Seven rats were chronically catheterized and were later studied
in the awake state. In preliminary surgery, conducted under
general anesthesia and using full sterile technique, catheters were
placed in the left femoral artery and vein and in the urinary
bladder. The vascular catheters were exteriorized at the back of
the neck, primed with heparin (500 U/mi), and plugged. The
bladder was irrigated with neomycin and plugged so that rats were
able to void normally through the urethra. Further details of this
preparation are given elsewhere [3, 14, 15]. At least seven days
were allowed for full recovery after surgery. Before experiments,
rats received extensive handling and were trained to sit quietly in
a restraining cage for intervals of three to four hours.
A total of seven groups were studied and these are summarized
in Table 1. Group I experiments were conducted on conscious
rats as follows: Rats were placed in a restraining cage and the
bladder pin removed for urine collection. The arterial catheter
was connected to a pressure transducer and recorder (ICT -2H
Demograph; Gilson, Middleton, WI, USA) for continual record-
ing except for occasional sampling of arterial blood. An i.v.
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Table 1. Groups of rats
Group 1: Conscious, chronically instrumented, time control, N = 7
Group 2: Anesthetized, acutely prepared, time control, N = 9
Group 3: Anesthetized, acutely prepared, aminoguanidine pretreated,N=8
Group 4: Anesthetized, acutely prepared, dexamethasone pretreated, N
=6
Group 5: Conscious rats (previously Group I), studied in control and
then given increasing doses of L-NAME, N = 7
Group 6: Anesthetized, acutely prepared rats, previously studied in the
awake state ("conditioned") in Group 1 and 5 experiments, +
L-NAME, N = 6
Group 7: Anesthetized, acutely prepared, + L-NAME, N 8
infusion of 0.9% NaCI containing tritiated inulin (2 to 5 jxCi/ml)
and p-aminohippuric acid (PAH; 1%) was given at the rate of 5
ixl/min/100 g body wt (body wt). This is a non-expanding infusion
rate which approximately equals urine flow in this preparation.
After —90 minutes, when plasma inulin and PAH concentrations
had plateaued, 5 consecutive 25-minute urine collections were
made with midpont arterial blood samples (150 pA). After centrif-
ugation and removal of plasma for later analysis (see below), the
red cells were reconstituted with an equal volume of sterile,
isotonic saline and returned to the rat. During the first and last
clearance period, additional plasma (150 pA) was collected and
mixed with 10 pA isobutyl-niethyl xanthine, 0.5 m final, to inhibit
cGMP breakdown. Both plasma and urine were stored at —70°C
until measurements were made of NOx and cGMP (see below).
At the end of this experiment, vascular and bladder catheters were
primed and plugged and rats were returned to their home cages.
One week later these same rats (now Group 5) were again studied
in the awake state before and during L-NAME administration
(see below).
Thirty-one additional rats were acutely prepared and studied
under general anesthesia (intraperitoneal thiobarbiturate, mactin,
120 mg/kg) as follows: Rectal temperature was maintained at 37°C
and euvolemia (volume restoration) [7] was produced by infusion
of a 5% artificial protein solution (2.5% bovine serum albumin,
2.5% bovine globulin in lactated Ringer), initially at 1% body
wt/hr for 45 minutes during the preparatory surgery, then at
0.15% body wt/hr throughout the experiment. Surgery included a
tracheotomy, placement of intravenous catheters for infusions, a
carotid artery catheter for measurement of mean arterial pressure
(BP) and for blood samplings. The left kidney was exposed
through ventral midline and left subcostal incisions, the left ureter
was cannulated and the left kidney was immobilized. Details of
this preparation have been published previously [16]. An i.v.
infusion of 0.9% NaCl containing tritiated inulin (2 to 5 jxCi/ml)
and p-aminohippuric acid (PAH; 1%) was given at 5 jl/100 glmin
for 80 minutes prior to beginning 5 >< 25 minutes clearance
periods. The first clearance period was begun —80 to 90 minutes
after surgery began and the fifth and final period was -=190 to 215
minutes after the first surgical incision.
Five groups (Groups 2, 3, 4, 6, 7) of acutely prepared, anesthe-
tized rats were employed (Table 1): Group 2, no pre-treatment
(N = 8); Group 3, aminoguanidine, pre-treatment (AG, Aldrich,
Milwaukee, WI, USA; 25 mg/100 g body wt by gavage, 18 and 1 hr
before surgery, N = 8); and Group 4, dexamethasone pre-
treatment (Dex; American Regent, Shirley, NY, USA; 5 jxglrat, in
100 pA water, s.c., 18 hr before surgery, N = 6). These doses of AG
and Dcx have previously been shown to selectively inhibit the
iNOS [12, 13]. Group 7 rats (N = 8) were studied in two X
25-minute control clearance periods, then were subjected to
nonselective NOS inhibition with L-NAME, as follows. The first
dose of L-NAME was an iv. bolus of 0.03 mg/lOU g (in 45 j.Ll
saline/100 g) followed by 25 minutes infusion of 0.003 mg/100
g/min (5 pA/lOU g/min). The second dose was 0.1 mg/100 g bolus,
then 25 minutes of infusion of 0.01 mg/lOU g/min, and the third
dose was 0.3 mg/lOU g bolus plus 0.03 mg/100 glmin infusion.
Infusates were prepared by dissolving L-NAME in the solution
containing inulin and PAH. During each 25-minute drug infusion
a clearance measurement was made. To see whether the cumula-
tively administered dose of L-NAME had exerted maximal effect
on arterial pressure, a final i.v. bolus of L-NAME (1.0 mg/I 00 g)
was given. Group 6 (N = 6; previously Group 1 and 5 rats), had
been chronically instrumented for three weeks and received
L-NAME seven days before, in the awake state. These Group 6
rats were prepared and studied under anesthesia exactly as
described above for Group 7.
The volumes of all urine samples were measured gravimetri-
cally and the urine was analyzed for tritiated inulin activity and
PAH concentration, then stored frozen for later analysis. Arterial
blood samples were analyzed for hematocrit (Hct), tritiated inulin
activity, and PAH concentration. Tritiated inulin activity was
measured in 10 pA samples of urine and plasma in a scintillation
counter. PAH concentration was measured colorimetrically, as
described previously [3, 14, 15, 17]. Plasma protein concentration
(CA) was measured on a refractometer. These measurements
allow calculation of inulin clearance, which equals glomerular
filtration rate (GFR), PAT-I clearance, which when factored for
renal PAH extraction = 0.85 [8] equals renal plasma (RPF), and
renal vascular resistance (RVR). These calculations are described
elsewhere [3, 14, 15, 17].
Later urine samples were analyzed for nitrite (NO2) and nitrate
(NO3) = NOx concentration, by the Griess assay as described by
us previously [17]. Measurement of cGMP was by the enzyme
immunoassay kit from the Cayman Chemical Company (Ann
Arbor, MI, USA). Samples were frozen until the day of the assay.
All samples were run in duplicate or triplicate and were diluted to
the mid-range of the assay curve. The intra- and interassay
coefficient of variation of the cGMP assay was 10%.
Data are expressed as mean SE. The SAS statistical software
was used for all analyses by ANOVA and the least significant
difference test or unpaired t-test. Dose dependency was analyzed
by linear regression.
Results
Effects of acute surgery on hemodynamics and the NO-cGMP
system
Body weights were similar in Groups I to 4: 245 7 g in Group
1, conscious rats; 255 8 g in Group 2, acutely prepared rats;
262 5 g in Group 3, acutely prepared rats pretreated with AG;
245 12 g in Group 4, acutely prepared rats pretreated with
DEX. Constancy of hematocrit (Hct) and CA can be used as an
index of relative constancy of plasma volume [7]. As shown in
Table 2, there was no difference in Hct or CA between the initial
value and that obtained at the beginning of the experiment in any
Group. Group 1, conscious rats exhibited a slight hemodilution
during the course of the experiment since period 5 values of Hct
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Table 2. Values of hematocrit (Hct) and plasma protein concentration (CA) at time 0, that is, within —15 mm of induction of anesthesia in Groups
2-4, 6 and 7 and at the beginning of the infusions in conscious Group 1 and 5 rats
Groups
Hct, vol% CA, g/dl
Time 0 Period 1 Period 5 Time 0 Period 1 Period 5
Group 1, no surgery, conscious
Group 2, surgery, anesth
Group 3, aminoguan. + surgery
Group 4, dexameth. + surgery
Group 5, conscious + L-NAME
Group 6, anesth., conditioned +
L-NAME
Group 7, anesth acutely
prepared + L-NAME
42 1
43 144 1
45 139 1
36 1
44 1
42 1
43 1
45 145 139 136 2
44 1
40 1
42 1
43 1
43 1
39 1
36 1
42 1
6.1 0.1
5.3 0.2
6.2 0.2
6.1 0.1
6.1 0.1
5.3 0.1
5.6 0.2
6.1 0.1
5.3 0.2
6.2 0.2
6.0 0.1
6.1 0.2
5.3 0.1
5.5 0.1
5.8 0.1
5.1 0.2
6.2 0.2
5.5 0.1
6.2 0.2
5.5 0.1
5.3 0.2
Data are mean SE.
Table 3. Blood pressure, renal vascular resistance and glomerular filtration rate (X SE) in conscious rats (Group 1) and in rats subjected to
micropuncture surgery and inhibition of iNOS (Groups 2—4)
Group
number Group
Clearance period
1 2 3 4 5
BP mm Hg
RVR mm Hg/mi!
1
2
3
4
1
no surgery (conscious, N = 7)
surgery (anesth., N = 9)
aminoguan. + surgery (N = 8)
dexameth. + surgery (N = 6)
no surgery
105 2
100 3
109 5
100 5
20.6 2.3
103 2
100 3
111 6
100 5
20.8 1.6
105 2
104 3
113 6
102 2
19.1 1.9
106 3
103 3
111 6
97 5
23.1 1.6
103 2
101 3
107 5
97 5
21.8 1.9
min/lOOg
GFR mi/min!100 g
2
3
4
I
2
3
4
surgery
aminoguan. + surgery
dexameth. + surgery
no surgery
surgery
aminoguan. + surgery
dexameth. + surgery
23.4 1.6
21.5 1.4
20.8 1.0
0.80 0.04
0.74 0.4
0.83 0.02
0.77 0.05
21.0 0.8
23.3 3.1
19.6 1.2
0.78 0.02
0.75 0.02
0.84 0.01
0.78 0.02
22.6 2.3
20.3 1.4
20.9 1.1
0.83 0.03
0.83 0.03
0.87 0.02
0.83 0.04
22.6 0.6
20.2 1.6
19.0 1.7
0.73 0.04
0.76 0.02
0.86 0.01
0.83 0.06
20.3 1.8
22.8 1.4
23.2 1.9
0.70 0.03
0.78 0.03
0.81 0.03
0.79 0.07
Abbreviations are: iNOS, inducible NO synthase; BP, mean arterial pressure; RVR, renal vascular resistance; GFR, glomerular filtration rate.
Clearance periods 1—5 indicate —90—115, 116—140, 141—165, 166—190, and 191—215 minutes after the initial incision in Groups 2—4.
and CA were both slightly lower than the zero (initial) values. In
all other groups, however, plasma volume was constant as evi-
denced by similarity of Hct and CA between initial and period 5
values, thus, in the anesthetized rats the euvolemic protocol was
effective in maintaining plasma volume.
Table 3 summarizes BP, RVR and GFR in Groups 1 to 4,
during the five consecutive clearance periods. There were no
differences in these variables between the conscious, chronically
prepared (Group 1) rats and the acutely prepared (Group 2) rats
at any time during the experiment. AG and Dex pretreatment had
no effect on hemodynamics of acutely prepared rats (Groups 3
and 4). Of note, the conscious (Group 1) and the acutely prepared
(Groups 2 to 4) rats were hemodynamically stable throughout the
five consecutive experimental periods (Table 3).
Table 4 summarizes the UNOXV, UCGMPV and urine flow (V)
data for Groups 1 to 4. In conscious rats UNOXV and UCGMPV
remained constant with time, and there was no change in cGMp
from period 1 to period S (Tables 4 and 5). In contrast, UNOXV
and UCGMPV rose with time in the acutely prepared, Group 2 rats
(Table 4 and Fig. 1) and cGMp was higher at period 5 versus
period 1 (Table 5). Pretreatment with AG or Dex prevented the
increases in UNOXV and UCGMPV (Table 4 and Fig. 1) and
converted the rise in cGMp seen with time in Group 2 rats, to a
fall in Groups 3 and 4 (Table 5). Urine flow (V) was variable in
Groups I to 4 (Table 4).
Effects of complete non-selective inhibition of NO synthesis in
conscious versus acutely prepared rats
Table 6 summarizes the hemodynamic data in Groups 5 to 7
rats, which received the nonselective NOS inhibitor L-NAME in
three graded doses. As with Groups I and 2, the control values of
BP and renal hemodynamics were similar between conscious
Group 5 and the acutely prepared Group 7 rats. Group 6 rats,
however, consisted of acutely prepared, anesthetized rats which
had previously been catheterized and studied in the conscious
state, as Group 1 and later Group 5 animals. These rats therefore
represent a "conditioned" group of acutely prepared animals. In
Group 6, BP was lower in control versus Group 5 or Group 7 rats.
There were no renal hemodynamic differences in the control,
baseline state between Group 6 and either Groups 5 or 7 rats.
Increasing doses of L-NAME produced dose dependent in-
creases in BP and RVR in Groups 5, 6 and 7. The pressor
response (expressed as % increase from control) was similar in
Groups S and 6 (38 3 and 34 5%, respectively) but was
blunted in acutely prepared, non-conditioned rats (Group 6, Fig.
2). The renal vasoconstrictor responses to graded L-NAME were
similar in Groups 5 and 7 but were attenuated in Group 6 acutely
prepared, "conditioned" rats (Table 6 and Fig. 2). GFR declined
in all rats after L-NAME, but was better preserved in the acutely
prepared rats, particularly Group 6. The final large bolus of
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Table 4. Effect of surgery and inhibition of iNOS on urinary (NO2 + NO1, NOX) and cGMP excretion and urine flow (V) (X SE)
Group
number Group
Clearance periods
1 2 3 4 5
UNQXV nmol/min/lOOg I
2
3
4
no surgery (conscious, N = 7)
surgery (anesth., N = 9)
aminoguan. + surgery (N = 8)
dexameth. + surgery (N = 6)
2.2 0.4
1.1 0.3'
1.3 0.3
0.8 0.3'
1.8 0.4
1.3 0.4
1.4 0.3
1.1 0.03
2.2 0.2
2.9 0.5
1.6 0.3
1.5 0.2
2.0 0.4
3.8 0.6a
1.4 0.3
1.6 0.3'
1.6 0.2
4.8 0.8'
1.3 0.3k
1.6 0.4k
U0Vpmol/!nin/IOOg 1
2
3
4
no surgery
surgery
aminoguan. + surgery
dexameth. + surgery
7.5 1.1
11.4 2.9
10.1 0.7
9.5 1.2
8.5 1.9
8.9 2.0
11.6 0.9
8.2 1.0
11.6 1.8
18.3 2.9
10.9 1.3
9.7 1.7
8.4 1.0
16.0 2.0
9.0 0.8
8.1 0.5
8.9 1.0
23.8 3.4"
10.0 10h
7.6 0.9l
Vpi/min/lOOg 1
2
3
4
no surgery
surgery
aminoguan. + surgery
dexameth. + surgery
10.2 1.4
5.9 2.0"
9.5 2.8
3.2 0.7"
6.6 0.9
5.1 1.3
10.3 3.0
3.0 0.4
12.1 2.1
8.3 2.7
15.9 2.5
33 03a,h
8.1 1.8
8.7 2.5
17.0 2•8b
3.2 0.4"
5.7 0.8
9.9 2.2
16.0 2.9k
4.6 1.2k
Clearance periods 1—S indicate —90—115, 116—140, 141—165, 166—190, and 191—215 minutes after initial incision in Groups 2—4.
a P < 0.05 or less vs. No surgery; ' P < 0.05 or less vs. Surgery
0
E
0z
106—130 131—155 156—180 181—205
L-NAME (1.0 mg/lOU g, i.v.) induced a further elevation of BP
only in Group 6 (from 122 5 mm Hg to 133 4, P < 0.05),
which indicated submaximal inhibition of NOS during the last
clearance period in the acutely prepared, pre-conditioned rats.
Table 7 summarizes UNOXV, UCGMPV and V for Groups 5 to 7.
In control, UNOXV was higher in conscious, Group 5, versus the
acutely prepared, Group 7 rats, although UCGMPV was similar,
exactly as observed in the first observation periods of Groups 1
and 2. In contrast, the "conditioned" Group 6 rats had the highest
control values of UNOXV. L-NAME caused a predictable fall in
UNOXV only in conscious (Group 5) rats but in marked contrast,
UNOXV did not fall with any dose of L-NAME in either Group 6
or 7 anesthetized rats, despite clear evidence of a NOS inhibition-
dependent rise in BP and RVR. V was not greatly influenced by
L-NAME in any group, but did increase versus the control value
in Group 7. UCGMPV was not affected by L-NAME except in
Group 7, acutely prepared rats where an anomalous increase was
seen with the highest dose of L-NAME (Table 7 and Fig. 2).
'GMP increased after L-NAME in Groups 5 and 7 (Table 5).
General anesthesia + acute surgical preparation made the
administration of L-NAME toxic, since 4 of 8 rats in Group 7 died
due to administration of the cumulative dose of L-NAME.
Autopsy of the four non-survivor rats revealed cardiac contracture
("stone heart"). In contrast, none of the conscious, chronically
prepared (0 of 7) or conditioned, acutely prepared rats (0 of 6)
died.
Time after start of surgery, minutes
Fig. 1. Change in urinary excretion of NO2 +N03 (LUNoxV) during the
2nd-5th renal clearance periods (from 116 to 215 mm after surgery), as
compared to period 2 (90 to 115 mm after start of surgery). Abbreviations
are: AG, aminoguanidine pretreatment; DEX, dexamethasone pretreat-
ment. Symbols are: (•) surgery; (7) DEX + surgery; (A) AG + surgery;(LI) no surgery. *p < 0.05 vs. "no surgery" (conscious, chronically
prepared) rats; #P < 0.05 vs. un-pretreated, acutely prepared rats
("surgery").
Relationship between humoral and hemodynamic indices of the
NO system
In conscious rats, UNOXV behaved as predicted by the activity
of the endogenous NO system and correlated inversely with BP
and RVR; that is, UNOXV, BP and RVR were stable with time
(Group 1) and UNOXV fell while BP and RVR increased during
acute, nonselective NOS inhibition (Group 5) (Tables 3, 4, 6 and
7). In contrast, in anesthetized rats of Groups 2, 3, 4, 6 and 7,
acute changes in UNOXV and UCGMPV in response to time or
manipulation of the NO system, did not correlate predictably with
BP or renal hemodynamic responses (Fig. 2). For example, in
Group 2 and 4, UNOXV increased without any accompanying
depressor or renal vasodilator response. In Group 7 (+ L-
NAME), increased BP and RVR due to nonselective NO synthe-
sis inhibition was associated with a paradoxical increase in UN-
oxV and UCGMPV. Further, UNOXV and UCGMPV were
dissociated in Groups 3, 4 and 6 (Fig. 2).
Table 5. Plasma cGMP concentrations (pmol/ml, X SE)
Clearance period
Group 1 5
-
Group I, no surgery, conscious 5.4 0.6 5.5 0.7
Group 2, surgery, anesth 5.7 0.9 8.2 07a,b
Group 3, aminoguan. + surgery 5.3 0.7 3.3 1.3k'
Group 4, dexameth. + surgery
Group 5, conscious + L-NAME
7.2 0.2"
5.7 1.6
4.5 05b
10.8 lla,
Group 6, anesth., conditioned + 10.5 1.4" 16.4 5.6
L-NAME
Group 7, anesth acutely prepared + 7.1 0.9 41.0 156a.b
L-NAME
a P < 0.05 vs. Group P < 0.05 vs. clearance period 1.
3
2
1
0
—1
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Table 6. Hemodynamics of L-NAME groups (K SE)
Group
number Group
Clearance period
1 2 3 4 5
Control
L-NAME (bolus + infusion, mg/100 glmin)
0.03 + 0.003 0.1 + 0.01 0.3 + 0.03
BPmm Hg 5
6
7
conscious (N = 7)
anesth., chron. instrumented (N =
acutely prep. (N = 8)
6)
102 2 103 2
94 i' 90 2
105 3 106 2
114 4" 132 3" 142 3"
101 109 3" 122 5"
113 3" 123 130
RVR mm Hg/mi!
min/100 g
5
6
7
conscious
anesth., chron. instrumented
acutely prep.
18.5 2.6 19.5 1.9
22.3 2.5 21.6 2.3
21.1 1.0 22.7 1.5
29.7 3.7" 39.6 58h 54.5 3.9"
25.6 2.0" 27.0 4.3" 38.2 6.2a
28.2 2.6" 38.3 2.8" 51.4 5.4"
GFR mi/min/100 g 5
6
7
conscious
anesth., chron. instrumented
acutely prep.
0.81 0.01 0.80 0.02
0.67 0.05 0.76 0.04
0.81 0.03 0.83 0.02
0.60 0.03" 0.60 0.04" 0.48 0.01"
0.8 0.04a 0.70 0.06 0.62 006a,h
0.78 0.04" 0.68 0.04" 0.58 0.05"
a P < 0.05 vs. conscious; hP < 0.05 vs. control (average of first and second control)
Discussion
In this study we report that, despite extensive surgery and
general anesthesia, BP and renal hemodynamics are similar to
those in rats seen in the awake, unstressed state. Thus, although
surgery/general anesthesia produce fluid shifts with falls in plasma
volume and cardiac output, and activation of the SNS and RAS
[7—101, the plasma infusion protocol that maintains plasma vol-
ume at the awake state (= euvolemia) is also effective in
maintaining BP and RVR. Most likely this "hemodynamic con-
stancy" of euvolemia results from offsetting, vasodilatory compen-
sation to the activated pressor systems.
The primary purpose of this study was to determine how acute,
nonsterile surgery conducted under general anesthesia influences
the activity of the NO/cGMP system, and what impact, if any, the
preparation has on the hemodynamic activity of endogenously
produced NO. This is a particularly pertinent line of inquiry, since
the majority of in vivo studies that investigate NO and hemody-
namics are conducted in acutely prepared, anesthetized animals.
We employed two approaches to investigate this question; the
urinary excretion of the stable NO oxidation products (UNOXV)
and the second messenger cGMP were used to provide an index of
overall NO production. In addition, the response to various NO
synthesis (NOS) inhibitors provided an insight into the origin of
the NO reflected by UNOXV. Further, the response to NOS
inhibition could define the hemodynamic role of NO generated by
various NOS. Since UNOXV reflected all NO generated, these
combined approaches should allow us to differentiate "hemody-
namically active" NO from other NO.
Comparison of conscious, chronically prepared (Group 1) and
anesthetized, acutely prepared (Group 2) rats demonstrates that
when all NOS are intact, acute nonsterile surgery and general
anesthesia increase UNOXV and UCGMPV during the course of the
experiment. Acute measurements of UNOXV have been used as
an index of systemic/renal NO production [18], although studies
by us [17] have shown that proximal tubular NO,, reabsorption is
a primary determinant of UNOXV. In fact, acute alterations in
UNOXV often do not correlate with changes in RVR due to
manipulation of the NO system, but rather, correlate with V when
proximal reabsorption is altered [17]. Therefore, the use of acute
changes in UNOXV as a valid measure of NO production is
unpredictable and will vary with the experimental design. In the
present study there is some evidence that the increase in UNOXV
with time after acute surgery, does, in fact reflect an increase in
total NO production. Parallel increases occur in UCGMPV, and the
major second messenger of NO and cGMp also increases with
time. Since cGMP is not usually handled by the tubule [19], this
parallelism between UNOXV and UCGMPV may reflect cause and
effect.
Another reason to suppose that the increase in UNOXV in
acutely prepared rats reflects increased NO production, is the
finding that increased UNOXV can be prevented by selective
inhibition of NO synthesis. Groups 3 and 4 acutely prepared rats
received the iNOS inhibitors AG and DEX, respectively [12, 13].
Both methods of iNOS inhibition prevent the increase in UNOXV,
UCGMJ,V and cGMp following general anesthesia/surgery. Since
the UNOXV response is dissociated from V, the reduction in
UNOXV with AG and DEX probably reflects a reduction in NO
synthesis rather than altered tubular handling of NOx.
Therefore, acute surgical preparation and/or general anesthesia
stimulate NO generation from iNOS. How might these interven-
tions activate NO generation from iNOS? Incisions were made,
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Fig. 2. Percent change in BP, RVR, UNOXV and UGMJY in anesthetized,
acutely prepared rats of Groups 2, 3, 4, 6, and 7 observed during the 515 versus
the 1a1 (control) clearance period. *p < 0.05 or less versus Group 2
(untreated); #P < 0.05 or less versus clearance period 1 (Tables 3 and 6).
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Table 7. NOx, cGMP and urine flow (V) of L-NAME rats (X SE)
Group
number Group
Clearance period
1 2 3 4 5
Control
L-NAME (bolus + infusion, mg/100 g/min)
0.03 + 0.003 0.1 + 0.01 0.3 + 0.03
UNOXV nmol/
min/lOOg
5
6
7
conscious (N = 7)
anesth., chron. instrumented (N =
acutely prep. (N = 8)
6)
2.36 0.39 2.06 0.38
4.87 0.85a 5.82 0.85a
0.78 0.19 1.45 0.42
1.39 0.16" 0.98 013b 0.89 0.1"
6.95 lisa 4.95 0.53" 3.35 0.56"
1.77 0.35 1.29 0.30 1.43 0.35
UCGMPVpm01/
rnin/100 g
5
6
7
conscious
anesth., chron. instrumented
acutely prep.
10.2 0.6 8.9 0.8
22.3 8.2 21.5 8.6
10.9 3.0 10.9 1.6
10.4 4.8 7.7 1.6 7.9 0.9
15.1 5.2 19.8 6.6 29.2 16.5
13.0 3.1 20.1 5.5 37.2 11.1'"
V pi/min/lOOg 5
6
7
conscious
anesth., chron. instrumented
acutely prep.
9.5 2.0 7.8 1.5
6.3 2.0 8.0 2.5
3.8 0.3" 5.9 1.0
7.0 0.9 10.1 3.4 13.4 5.8
10.8 3.0 10.1 3.4 10.2 2.4
9.4 1.7 10.3 3.4" 12.0 2.9"
"P < 0.05 vs. conscious; h P < 0.05 vs. control (average of first and second control)
blood vessels were catheterized and the left kidney was handled
during catheterization of the ureter. The incisions, minor bleed-
ing, temporary clamping (ischemia + reperfusion), cauterization,
local coagulation and platelet factors, introduction of foreign
material (such as polyethylene tubing; bovine albumin and glob-
ulin), and bacterial contamination due to non-sterile surgery, may
all activate macrophages to produce inflammatory mediators
including NO [1, 2, 20—22]. In humans undergoing major surgery,
several cytokines are released 120 minutes after sterile incision
[231, which can induce iNOS expression in various tissues includ-
ing macrophages [11 vascular smooth muscle cells [241 and
glomerular mesangial cells [25]. Since sterile technique is not
employed in acute experimental surgery, additional bacterial
stimuli are also likely to activate iNOS [13].
It therefore seems likely that acute, nonsterile surgery +
general anesthesia activate NO generation by iNOS. Surprisingly,
however, the iNOS dependent NO production has no impact on
BP or renal hemodynamics. This is suggested since BP and renal
hemodynamics are similar in awake and anesthetized, acutely
prepared rats, despite marked differences in total NO and cGMP
production. Also, selective inhibition of NO generation by iNOS
with either AG or DEX restores NO production to the awake
value, but has no impact on BP or renal hemodynamics. There-
fore, the response to nonsterile surgery, leading to activation of
iNOS, is apparently confined to the vicinity of direct tissue injury
and does not reach the resistance vessels to cause vasodilation/
hypotension.
We conducted a further series of experiments in awake and
acutely prepared, anesthetized rats, using the nonselective NOS
inhibitor L-NAME. As shown earlier, widespread NOS inhibition
produces dose dependent increases in BP and RVR [26]. Since
selective iNOS inhibition with either AG or DEX has no hemo-
dynamic effects, the pressor and renal vasoconstrictor responses
to L-NAME must result from inhibition of NO generated by
constitutively expressed NOS. A major finding from the present
studies is that in response to acute manipulation of NO genera-
tion, neither UNOXV nor UCGMPV change in a consistent, pre-
dictable fashion. The most extreme example is the observation in
Group 7 rats where massive vasoconstriction due to nonselective
NO synthesis inhibition is associated with paradoxical increases in
UNOXV, UCGMPV and 'GMP There are other examples, de-
scribed in Figure 2, where BP,RVR, UNOXV and/or UCGMPV
change in patterns that are not consistent with the status of the
"hemodynamically active" component of the NO system. The
present observations reinforce our earlier concerns [17] about the
validity of the use of acute UNOXV and/or UCGMPV as indices of
the activity of the NO system.
Another important finding in the present study is that whereas
inhibition of iNOS in acutely prepared, anesthetized rats was
harmless, nonselective inhibition of NOS by L-NAME was toxic.
Fifty percent of acutely prepared (non conditioned) rats, but none
of the chronically prepared rats died shortly after the administra-
tion of L-NAME in systolic cardiac arrest ("stone heart"). Cardiac
contracture is a manifestation of global myocardial ischemia [27]
and NO synthase inhibitors induce myocardial ischemia [28], and
cardiac depression [5, 29]. Acute surgical preparation itself leads
to a significant reduction in coronary blood flow [30] and L-
NAME aggravates this effect and causes a rapid deterioration of
cardiac function in some rats. Prior exposure to L-NAME and/or
surgery is protective since the previously catheterized, "condi-
tioned" rats showed no adverse response to acute L-NAME when
studied after acute surgical preparation. We have no information
at present on the mechanism by which conditioning is protective.
However, we speculate that NOS may be induced in some key
location such as the coronary vessels, leading to the protection
enjoyed by "conditioned" rats.
Our data on plasma and urinary cGMP confirm our [5, 17] and
other authors [31] earlier observations that cGMP recovered in
plasma or urine is not always consistent with change in NO
synthesis. Certainly, cGMP production may be modified by a
number of signals in addition to NO, including sympathetic
nervous system [32], the renin-angiotensin system [33] and partic-
ularly, atrial natriuretic peptide, [34, 35], In rats and rabbits [36]
atrial hypoxia stimulates release of ANP. In addition, NO defi-
ciency may result directly in ANP release, since NO is a negative
modulator of ANP release [37]. Finally, acute hypertension
secondary to L-NAME may also provide a direct stimulus for
ANP release [38].
Taken collectively, our results indicate that acute non-sterile
surgical preparation of rats results in a so-far unrecognized
increase of NO and cGMP production for which the de novo
expression of iNOS seems to be responsible. This NO of iNOS
origin has no impact on hemodynamics in this condition. Unfor-
tunately, acute alterations in UNOXV and/or UCGMPV are not
Losonczy et a!: Nitric oxide, anesthesia and surgery 1949
always predictive of anticipated changes in total NO synthesis, and
do not correlate with hemodynamic alterations. In addition, while
large doses of the nonselective NOS inhibitor L-NAME are well
tolerated by chronically prepared rats and acutely prepared
"pre-conditioned" rats, 50% of the "non-conditioned" acutely-
prepared rats developed cardiac contracture.
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